APO Research
Talk to an analyst

APO RESEARCH · REPORT

Open-Angle Glaucoma Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Open-Angle Glaucoma Therapeutics Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchOpen-Angle Glaucoma Therapeutics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Open-Angle Glaucoma Therapeutics Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Open-Angle Glaucoma Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Open-Angle Glaucoma Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Open-Angle Glaucoma Therapeutics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Open-Angle Glaucoma Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Open-Angle Glaucoma Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Open-Angle Glaucoma Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Open-Angle Glaucoma Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Open-Angle Glaucoma Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Open-Angle Glaucoma Therapeutics include Novartis AG, Pfizer Inc., Bausch Health Companies, Inc., Allergan Plc and Aerie Pharmaceuticals Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Open-Angle Glaucoma Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Open-Angle Glaucoma Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Open-Angle Glaucoma Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Open-Angle Glaucoma Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Open-Angle Glaucoma Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Open-Angle Glaucoma Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Open-Angle Glaucoma Therapeutics Segment by Company

Novartis AG

Pfizer Inc.

Bausch Health Companies, Inc.

Allergan Plc

Aerie Pharmaceuticals Inc.

Open-Angle Glaucoma Therapeutics Segment by Type

Prostaglandin Analogs (PGAs)

Combination of PGAs

Other

Open-Angle Glaucoma Therapeutics Segment by Application

Clinic

Hospital

Research Institute

Other

Open-Angle Glaucoma Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Open-Angle Glaucoma Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Open-Angle Glaucoma Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Open-Angle Glaucoma Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Open-Angle Glaucoma Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Open-Angle Glaucoma Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Open-Angle Glaucoma Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prostaglandin Analogs (PGAs) Major Player Table 3. Combination of PGAs Major Player Table 4. Other Major Player Table 5. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Player Table 7. Hospital Major Player Table 8. Research Institute Major Player Table 9. Other Major Player Table 10. Open-Angle Glaucoma Therapeutics Industry Trends Table 11. Open-Angle Glaucoma Therapeutics Industry Drivers Table 12. Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges Table 13. Open-Angle Glaucoma Therapeutics Industry Restraints Table 14. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2021-2026) Table 17. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2027-2032) Table 19. Global Open-Angle Glaucoma Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2021-2026) Table 21. Global Open-Angle Glaucoma Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Open-Angle Glaucoma Therapeutics Key Players Headquarters & Area Served Table 23. Global Open-Angle Glaucoma Therapeutics Players, Product Type & Application Table 24. Global Open-Angle Glaucoma Therapeutics Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Open-Angle Glaucoma Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Open-Angle Glaucoma Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2021-2026) Table 31. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2027-2032) Table 32. Global Open-Angle Glaucoma Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2021-2026) Table 36. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2027-2032) Table 37. Novartis AG Company Information Table 38. Novartis AG Business Overview Table 39. Novartis AG Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio Table 41. Novartis AG Recent Development Table 42. Pfizer Inc. Company Information Table 43. Pfizer Inc. Business Overview Table 44. Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 46. Pfizer Inc. Recent Development Table 47. Bausch Health Companies, Inc. Company Information Table 48. Bausch Health Companies, Inc. Business Overview Table 49. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 51. Bausch Health Companies, Inc. Recent Development Table 52. Allergan Plc Company Information Table 53. Allergan Plc Business Overview Table 54. Allergan Plc Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio Table 56. Allergan Plc Recent Development Table 57. Aerie Pharmaceuticals Inc. Company Information Table 58. Aerie Pharmaceuticals Inc. Business Overview Table 59. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 61. Aerie Pharmaceuticals Inc. Recent Development Table 62. North America Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 65. North America Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 66. North America Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. North America Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 68. North America Open-Angle Glaucoma Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 69. Europe Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 70. Europe Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 71. Europe Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 72. Europe Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 73. Europe Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. Europe Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 75. Europe Open-Angle Glaucoma Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 76. China Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 77. China Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 78. China Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 79. China Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 80. Asia Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 81. Asia Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 82. Asia Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 83. Asia Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia Open-Angle Glaucoma Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Asia Open-Angle Glaucoma Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 86. Asia Open-Angle Glaucoma Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 87. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 88. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 89. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 90. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 91. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 93. SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Open-Angle Glaucoma Therapeutics Image Figure 2. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Open-Angle Glaucoma Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prostaglandin Analogs (PGAs) Image Figure 5. Combination of PGAs Image Figure 6. Other Image Figure 7. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Open-Angle Glaucoma Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Research Institute Image Figure 12. Other Image Figure 13. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million) & (2021-2032) Figure 14. Global Open-Angle Glaucoma Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Open-Angle Glaucoma Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Open-Angle Glaucoma Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Open-Angle Glaucoma Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2021-2032) Figure 21. Global Open-Angle Glaucoma Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2021-2032) Figure 24. North America Open-Angle Glaucoma Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032) Figure 26. North America Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032) Figure 27. North America Open-Angle Glaucoma Therapeutics Revenue Share by Country (2021-2032) Figure 28. United States Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Open-Angle Glaucoma Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032) Figure 33. Europe Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032) Figure 34. Europe Open-Angle Glaucoma Therapeutics Revenue Share by Country (2021-2032) Figure 35. Germany Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Open-Angle Glaucoma Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032) Figure 45. China Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032) Figure 46. Asia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032) Figure 48. Asia Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032) Figure 49. Asia Open-Angle Glaucoma Therapeutics Revenue Share by Region (2021-2032) Figure 50. Japan Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Open-Angle Glaucoma Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032) Figure 58. SAMEA Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032) Figure 59. SAMEA Open-Angle Glaucoma Therapeutics Revenue Share by Country (2021-2032) Figure 60. Brazil Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Open-Angle Glaucoma Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Prostaglandin Analogs (PGAs)
  • Combination of PGAs
  • Other
Applications
  • Clinic
  • Hospital
  • Research Institute
  • Other
Companies covered
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies, Inc.
  • Allergan Plc
  • Aerie Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Open-Angle Glaucoma Therapeutics Market by Type
  3. 1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prostaglandin Analogs (PGAs)
  5. 1.2.3 Combination of PGAs
  6. 1.2.4 Other
  7. 1.3 Open-Angle Glaucoma Therapeutics Market by Application
  8. 1.3.1 Global Open-Angle Glaucoma Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Research Institute
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Open-Angle Glaucoma Therapeutics Market Dynamics
  1. 2.1 Open-Angle Glaucoma Therapeutics Industry Trends
  2. 2.2 Open-Angle Glaucoma Therapeutics Industry Drivers
  3. 2.3 Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges
  4. 2.4 Open-Angle Glaucoma Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Open-Angle Glaucoma Therapeutics Growth Trends by Region
  3. 3.2.1 Global Open-Angle Glaucoma Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Open-Angle Glaucoma Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Open-Angle Glaucoma Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Open-Angle Glaucoma Therapeutics Revenue by Players
  2. 4.1.1 Global Open-Angle Glaucoma Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Open-Angle Glaucoma Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Open-Angle Glaucoma Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Open-Angle Glaucoma Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Open-Angle Glaucoma Therapeutics Players, Product Type & Application
  8. 4.5 Global Open-Angle Glaucoma Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Open-Angle Glaucoma Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Open-Angle Glaucoma Therapeutics Tier 1, Tier 2, and Tier 3
5 Open-Angle Glaucoma Therapeutics Market Size by Type
  1. 5.1 Global Open-Angle Glaucoma Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2021-2032)
6 Open-Angle Glaucoma Therapeutics Market Size by Application
  1. 6.1 Global Open-Angle Glaucoma Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 Bausch Health Companies, Inc.
  14. 7.3.1 Bausch Health Companies, Inc. Company Information
  15. 7.3.2 Bausch Health Companies, Inc. Business Overview
  16. 7.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  18. 7.3.5 Bausch Health Companies, Inc. Recent Developments
  19. 7.4 Allergan Plc
  20. 7.4.1 Allergan Plc Company Information
  21. 7.4.2 Allergan Plc Business Overview
  22. 7.4.3 Allergan Plc Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio
  24. 7.4.5 Allergan Plc Recent Developments
  25. 7.5 Aerie Pharmaceuticals Inc.
  26. 7.5.1 Aerie Pharmaceuticals Inc. Company Information
  27. 7.5.2 Aerie Pharmaceuticals Inc. Business Overview
  28. 7.5.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  30. 7.5.5 Aerie Pharmaceuticals Inc. Recent Developments
8 North America
  1. 8.1 North America Open-Angle Glaucoma Therapeutics Revenue (2021-2032)
  2. 8.2 North America Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Open-Angle Glaucoma Therapeutics Revenue by Country
  11. 8.6.1 North America Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Open-Angle Glaucoma Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Open-Angle Glaucoma Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Open-Angle Glaucoma Therapeutics Revenue by Country
  11. 9.6.1 Europe Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Open-Angle Glaucoma Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Open-Angle Glaucoma Therapeutics Revenue (2021-2032)
  2. 10.2 China Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Open-Angle Glaucoma Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Open-Angle Glaucoma Therapeutics Revenue by Country
  11. 11.6.1 Asia Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Open-Angle Glaucoma Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Open-Angle Glaucoma Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Open-Angle Glaucoma Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Open-Angle Glaucoma Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Open-Angle Glaucoma Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst